nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—ABCC1—Epirubicin—urinary bladder cancer	0.107	0.177	CbGbCtD
Mifepristone—ABCB1—Mitomycin—urinary bladder cancer	0.0979	0.162	CbGbCtD
Mifepristone—ABCC1—Etoposide—urinary bladder cancer	0.0834	0.138	CbGbCtD
Mifepristone—ABCC1—Doxorubicin—urinary bladder cancer	0.0569	0.0941	CbGbCtD
Mifepristone—ABCC1—Methotrexate—urinary bladder cancer	0.0551	0.0911	CbGbCtD
Mifepristone—CYP3A4—Thiotepa—urinary bladder cancer	0.0445	0.0735	CbGbCtD
Mifepristone—CYP3A5—Etoposide—urinary bladder cancer	0.0309	0.0511	CbGbCtD
Mifepristone—ABCB1—Gemcitabine—urinary bladder cancer	0.0282	0.0466	CbGbCtD
Mifepristone—AR—scrotum—urinary bladder cancer	0.0211	0.222	CbGeAlD
Mifepristone—ABCB1—Cisplatin—urinary bladder cancer	0.0205	0.0339	CbGbCtD
Mifepristone—ABCB1—Etoposide—urinary bladder cancer	0.0201	0.0333	CbGbCtD
Mifepristone—ABCB1—Doxorubicin—urinary bladder cancer	0.0137	0.0227	CbGbCtD
Mifepristone—ABCB1—Methotrexate—urinary bladder cancer	0.0133	0.022	CbGbCtD
Mifepristone—CYP2D6—Doxorubicin—urinary bladder cancer	0.0129	0.0214	CbGbCtD
Mifepristone—CYP3A4—Etoposide—urinary bladder cancer	0.0121	0.0199	CbGbCtD
Mifepristone—AR—penis—urinary bladder cancer	0.0095	0.1	CbGeAlD
Mifepristone—CYP3A4—Doxorubicin—urinary bladder cancer	0.00822	0.0136	CbGbCtD
Mifepristone—NR3C1—urine—urinary bladder cancer	0.00458	0.0483	CbGeAlD
Mifepristone—CYP3A4—urine—urinary bladder cancer	0.00346	0.0365	CbGeAlD
Mifepristone—CYP2D6—urine—urinary bladder cancer	0.00341	0.036	CbGeAlD
Mifepristone—PGR—prostate gland—urinary bladder cancer	0.00285	0.0301	CbGeAlD
Mifepristone—AR—prostate gland—urinary bladder cancer	0.00227	0.0239	CbGeAlD
Mifepristone—ABCC1—prostate gland—urinary bladder cancer	0.00216	0.0227	CbGeAlD
Mifepristone—PGR—epithelium—urinary bladder cancer	0.00209	0.0221	CbGeAlD
Mifepristone—PGR—smooth muscle tissue—urinary bladder cancer	0.00202	0.0213	CbGeAlD
Mifepristone—AR—seminal vesicle—urinary bladder cancer	0.00192	0.0203	CbGeAlD
Mifepristone—ABCC1—seminal vesicle—urinary bladder cancer	0.00182	0.0192	CbGeAlD
Mifepristone—AR—epithelium—urinary bladder cancer	0.00167	0.0176	CbGeAlD
Mifepristone—CYP3A5—prostate gland—urinary bladder cancer	0.00166	0.0175	CbGeAlD
Mifepristone—NR3C1—prostate gland—urinary bladder cancer	0.00164	0.0173	CbGeAlD
Mifepristone—AR—smooth muscle tissue—urinary bladder cancer	0.00161	0.017	CbGeAlD
Mifepristone—PGR—female reproductive system—urinary bladder cancer	0.00155	0.0164	CbGeAlD
Mifepristone—AR—renal system—urinary bladder cancer	0.00155	0.0163	CbGeAlD
Mifepristone—AR—urethra—urinary bladder cancer	0.00152	0.016	CbGeAlD
Mifepristone—ABCC1—urethra—urinary bladder cancer	0.00144	0.0152	CbGeAlD
Mifepristone—PGR—vagina—urinary bladder cancer	0.00141	0.0148	CbGeAlD
Mifepristone—NR3C1—seminal vesicle—urinary bladder cancer	0.00139	0.0147	CbGeAlD
Mifepristone—AR—female reproductive system—urinary bladder cancer	0.00124	0.0131	CbGeAlD
Mifepristone—NR3C1—epithelium—urinary bladder cancer	0.00121	0.0127	CbGeAlD
Mifepristone—NR3C1—smooth muscle tissue—urinary bladder cancer	0.00116	0.0123	CbGeAlD
Mifepristone—CYP3A5—renal system—urinary bladder cancer	0.00113	0.0119	CbGeAlD
Mifepristone—AR—vagina—urinary bladder cancer	0.00112	0.0118	CbGeAlD
Mifepristone—NR3C1—renal system—urinary bladder cancer	0.00112	0.0118	CbGeAlD
Mifepristone—NR3C1—urethra—urinary bladder cancer	0.0011	0.0116	CbGeAlD
Mifepristone—ABCC1—vagina—urinary bladder cancer	0.00106	0.0112	CbGeAlD
Mifepristone—PGR—lymph node—urinary bladder cancer	0.00091	0.0096	CbGeAlD
Mifepristone—NR3C1—female reproductive system—urinary bladder cancer	0.000897	0.00947	CbGeAlD
Mifepristone—ABCB1—prostate gland—urinary bladder cancer	0.00088	0.00928	CbGeAlD
Mifepristone—CYP3A4—renal system—urinary bladder cancer	0.000847	0.00894	CbGeAlD
Mifepristone—CYP2D6—renal system—urinary bladder cancer	0.000834	0.0088	CbGeAlD
Mifepristone—CYP3A5—vagina—urinary bladder cancer	0.000818	0.00863	CbGeAlD
Mifepristone—NR3C1—vagina—urinary bladder cancer	0.000811	0.00856	CbGeAlD
Mifepristone—ABCB1—seminal vesicle—urinary bladder cancer	0.000744	0.00785	CbGeAlD
Mifepristone—AR—lymph node—urinary bladder cancer	0.000725	0.00765	CbGeAlD
Mifepristone—ABCC1—lymph node—urinary bladder cancer	0.000688	0.00726	CbGeAlD
Mifepristone—CYP3A4—female reproductive system—urinary bladder cancer	0.000679	0.00716	CbGeAlD
Mifepristone—CYP2D6—female reproductive system—urinary bladder cancer	0.000668	0.00705	CbGeAlD
Mifepristone—ABCB1—epithelium—urinary bladder cancer	0.000647	0.00682	CbGeAlD
Mifepristone—ABCB1—renal system—urinary bladder cancer	0.0006	0.00633	CbGeAlD
Mifepristone—ABCB1—urethra—urinary bladder cancer	0.000589	0.00622	CbGeAlD
Mifepristone—NR3C1—lymph node—urinary bladder cancer	0.000525	0.00554	CbGeAlD
Mifepristone—ABCB1—female reproductive system—urinary bladder cancer	0.00048	0.00507	CbGeAlD
Mifepristone—ABCB1—vagina—urinary bladder cancer	0.000434	0.00458	CbGeAlD
Mifepristone—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000334	0.0019	CcSEcCtD
Mifepristone—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000333	0.00189	CcSEcCtD
Mifepristone—Insomnia—Fluorouracil—urinary bladder cancer	0.000332	0.00189	CcSEcCtD
Mifepristone—Somnolence—Gemcitabine—urinary bladder cancer	0.000332	0.00189	CcSEcCtD
Mifepristone—Anorexia—Cisplatin—urinary bladder cancer	0.000331	0.00189	CcSEcCtD
Mifepristone—Hypokalaemia—Epirubicin—urinary bladder cancer	0.000331	0.00188	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00033	0.00188	CcSEcCtD
Mifepristone—Discomfort—Etoposide—urinary bladder cancer	0.000328	0.00187	CcSEcCtD
Mifepristone—Breast disorder—Epirubicin—urinary bladder cancer	0.000328	0.00187	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.000327	0.00186	CcSEcCtD
Mifepristone—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000327	0.00186	CcSEcCtD
Mifepristone—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000327	0.00186	CcSEcCtD
Mifepristone—Somnolence—Fluorouracil—urinary bladder cancer	0.000326	0.00186	CcSEcCtD
Mifepristone—Hypotension—Cisplatin—urinary bladder cancer	0.000325	0.00185	CcSEcCtD
Mifepristone—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.000325	0.00185	CcSEcCtD
Mifepristone—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000324	0.00185	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000322	0.00183	CcSEcCtD
Mifepristone—Fatigue—Gemcitabine—urinary bladder cancer	0.000322	0.00183	CcSEcCtD
Mifepristone—Muscular weakness—Epirubicin—urinary bladder cancer	0.00032	0.00183	CcSEcCtD
Mifepristone—Pain—Gemcitabine—urinary bladder cancer	0.000319	0.00182	CcSEcCtD
Mifepristone—Constipation—Gemcitabine—urinary bladder cancer	0.000319	0.00182	CcSEcCtD
Mifepristone—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000319	0.00182	CcSEcCtD
Mifepristone—Asthenia—Thiotepa—urinary bladder cancer	0.000318	0.00181	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000317	0.0018	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000317	0.0018	CcSEcCtD
Mifepristone—Infection—Etoposide—urinary bladder cancer	0.000316	0.0018	CcSEcCtD
Mifepristone—Pruritus—Thiotepa—urinary bladder cancer	0.000314	0.00179	CcSEcCtD
Mifepristone—Pain—Fluorouracil—urinary bladder cancer	0.000314	0.00179	CcSEcCtD
Mifepristone—Dyspnoea—Cisplatin—urinary bladder cancer	0.00031	0.00177	CcSEcCtD
Mifepristone—Skin disorder—Etoposide—urinary bladder cancer	0.000309	0.00176	CcSEcCtD
Mifepristone—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000307	0.00175	CcSEcCtD
Mifepristone—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.000306	0.00174	CcSEcCtD
Mifepristone—Breast disorder—Doxorubicin—urinary bladder cancer	0.000304	0.00173	CcSEcCtD
Mifepristone—Anorexia—Etoposide—urinary bladder cancer	0.000304	0.00173	CcSEcCtD
Mifepristone—Diarrhoea—Thiotepa—urinary bladder cancer	0.000303	0.00173	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.000303	0.00172	CcSEcCtD
Mifepristone—Decreased appetite—Cisplatin—urinary bladder cancer	0.000302	0.00172	CcSEcCtD
Mifepristone—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000302	0.00172	CcSEcCtD
Mifepristone—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.000301	0.00171	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.0003	0.00171	CcSEcCtD
Mifepristone—Infestation—Methotrexate—urinary bladder cancer	0.000299	0.0017	CcSEcCtD
Mifepristone—Infestation NOS—Methotrexate—urinary bladder cancer	0.000299	0.0017	CcSEcCtD
Mifepristone—Hypotension—Etoposide—urinary bladder cancer	0.000298	0.0017	CcSEcCtD
Mifepristone—Pain—Cisplatin—urinary bladder cancer	0.000297	0.00169	CcSEcCtD
Mifepristone—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000296	0.00169	CcSEcCtD
Mifepristone—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000295	0.00168	CcSEcCtD
Mifepristone—Dizziness—Thiotepa—urinary bladder cancer	0.000293	0.00167	CcSEcCtD
Mifepristone—Urticaria—Fluorouracil—urinary bladder cancer	0.000291	0.00166	CcSEcCtD
Mifepristone—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00029	0.00165	CcSEcCtD
Mifepristone—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000286	0.00163	CcSEcCtD
Mifepristone—Dyspnoea—Etoposide—urinary bladder cancer	0.000284	0.00162	CcSEcCtD
Mifepristone—Somnolence—Etoposide—urinary bladder cancer	0.000283	0.00161	CcSEcCtD
Mifepristone—Vomiting—Thiotepa—urinary bladder cancer	0.000282	0.00161	CcSEcCtD
Mifepristone—ABCB1—lymph node—urinary bladder cancer	0.000281	0.00296	CbGeAlD
Mifepristone—Infestation NOS—Epirubicin—urinary bladder cancer	0.00028	0.0016	CcSEcCtD
Mifepristone—Infestation—Epirubicin—urinary bladder cancer	0.00028	0.0016	CcSEcCtD
Mifepristone—Rash—Thiotepa—urinary bladder cancer	0.00028	0.00159	CcSEcCtD
Mifepristone—Dermatitis—Thiotepa—urinary bladder cancer	0.000279	0.00159	CcSEcCtD
Mifepristone—Headache—Thiotepa—urinary bladder cancer	0.000278	0.00158	CcSEcCtD
Mifepristone—Decreased appetite—Etoposide—urinary bladder cancer	0.000277	0.00158	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000275	0.00157	CcSEcCtD
Mifepristone—Body temperature increased—Cisplatin—urinary bladder cancer	0.000275	0.00157	CcSEcCtD
Mifepristone—Fatigue—Etoposide—urinary bladder cancer	0.000275	0.00156	CcSEcCtD
Mifepristone—Pain—Etoposide—urinary bladder cancer	0.000272	0.00155	CcSEcCtD
Mifepristone—Constipation—Etoposide—urinary bladder cancer	0.000272	0.00155	CcSEcCtD
Mifepristone—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00027	0.00154	CcSEcCtD
Mifepristone—Haemoglobin—Methotrexate—urinary bladder cancer	0.00027	0.00154	CcSEcCtD
Mifepristone—Haemorrhage—Methotrexate—urinary bladder cancer	0.000269	0.00153	CcSEcCtD
Mifepristone—Asthenia—Gemcitabine—urinary bladder cancer	0.000268	0.00152	CcSEcCtD
Mifepristone—Pruritus—Gemcitabine—urinary bladder cancer	0.000264	0.0015	CcSEcCtD
Mifepristone—Nausea—Thiotepa—urinary bladder cancer	0.000263	0.0015	CcSEcCtD
Mifepristone—Sinusitis—Epirubicin—urinary bladder cancer	0.000263	0.0015	CcSEcCtD
Mifepristone—Feeling abnormal—Etoposide—urinary bladder cancer	0.000262	0.0015	CcSEcCtD
Mifepristone—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00026	0.00148	CcSEcCtD
Mifepristone—Pruritus—Fluorouracil—urinary bladder cancer	0.000259	0.00148	CcSEcCtD
Mifepristone—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000259	0.00148	CcSEcCtD
Mifepristone—Infestation—Doxorubicin—urinary bladder cancer	0.000259	0.00148	CcSEcCtD
Mifepristone—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000256	0.00146	CcSEcCtD
Mifepristone—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000255	0.00145	CcSEcCtD
Mifepristone—Urticaria—Etoposide—urinary bladder cancer	0.000253	0.00144	CcSEcCtD
Mifepristone—Haemoglobin—Epirubicin—urinary bladder cancer	0.000253	0.00144	CcSEcCtD
Mifepristone—Abdominal pain—Etoposide—urinary bladder cancer	0.000252	0.00143	CcSEcCtD
Mifepristone—Body temperature increased—Etoposide—urinary bladder cancer	0.000252	0.00143	CcSEcCtD
Mifepristone—Haemorrhage—Epirubicin—urinary bladder cancer	0.000251	0.00143	CcSEcCtD
Mifepristone—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000251	0.00143	CcSEcCtD
Mifepristone—Asthenia—Cisplatin—urinary bladder cancer	0.000249	0.00142	CcSEcCtD
Mifepristone—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000248	0.00141	CcSEcCtD
Mifepristone—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000247	0.00141	CcSEcCtD
Mifepristone—Angiopathy—Methotrexate—urinary bladder cancer	0.000244	0.00139	CcSEcCtD
Mifepristone—Sinusitis—Doxorubicin—urinary bladder cancer	0.000243	0.00138	CcSEcCtD
Mifepristone—Dizziness—Fluorouracil—urinary bladder cancer	0.000242	0.00138	CcSEcCtD
Mifepristone—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000242	0.00138	CcSEcCtD
Mifepristone—Chills—Methotrexate—urinary bladder cancer	0.000241	0.00137	CcSEcCtD
Mifepristone—Diarrhoea—Cisplatin—urinary bladder cancer	0.000238	0.00136	CcSEcCtD
Mifepristone—Vomiting—Gemcitabine—urinary bladder cancer	0.000237	0.00135	CcSEcCtD
Mifepristone—Mental disorder—Methotrexate—urinary bladder cancer	0.000235	0.00134	CcSEcCtD
Mifepristone—Rash—Gemcitabine—urinary bladder cancer	0.000235	0.00134	CcSEcCtD
Mifepristone—Dermatitis—Gemcitabine—urinary bladder cancer	0.000235	0.00134	CcSEcCtD
Mifepristone—Hypersensitivity—Etoposide—urinary bladder cancer	0.000235	0.00134	CcSEcCtD
Mifepristone—Malnutrition—Methotrexate—urinary bladder cancer	0.000234	0.00133	CcSEcCtD
Mifepristone—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000234	0.00133	CcSEcCtD
Mifepristone—Headache—Gemcitabine—urinary bladder cancer	0.000234	0.00133	CcSEcCtD
Mifepristone—Vomiting—Fluorouracil—urinary bladder cancer	0.000233	0.00133	CcSEcCtD
Mifepristone—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000233	0.00132	CcSEcCtD
Mifepristone—Rash—Fluorouracil—urinary bladder cancer	0.000231	0.00132	CcSEcCtD
Mifepristone—Dermatitis—Fluorouracil—urinary bladder cancer	0.000231	0.00132	CcSEcCtD
Mifepristone—Headache—Fluorouracil—urinary bladder cancer	0.00023	0.00131	CcSEcCtD
Mifepristone—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000229	0.00131	CcSEcCtD
Mifepristone—Asthenia—Etoposide—urinary bladder cancer	0.000229	0.0013	CcSEcCtD
Mifepristone—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000228	0.0013	CcSEcCtD
Mifepristone—Angiopathy—Epirubicin—urinary bladder cancer	0.000228	0.0013	CcSEcCtD
Mifepristone—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000226	0.00129	CcSEcCtD
Mifepristone—Back pain—Methotrexate—urinary bladder cancer	0.000226	0.00129	CcSEcCtD
Mifepristone—Chills—Epirubicin—urinary bladder cancer	0.000225	0.00128	CcSEcCtD
Mifepristone—Pruritus—Etoposide—urinary bladder cancer	0.000225	0.00128	CcSEcCtD
Mifepristone—Nausea—Gemcitabine—urinary bladder cancer	0.000222	0.00126	CcSEcCtD
Mifepristone—Vomiting—Cisplatin—urinary bladder cancer	0.000221	0.00126	CcSEcCtD
Mifepristone—Mental disorder—Epirubicin—urinary bladder cancer	0.00022	0.00125	CcSEcCtD
Mifepristone—Rash—Cisplatin—urinary bladder cancer	0.000219	0.00125	CcSEcCtD
Mifepristone—Dermatitis—Cisplatin—urinary bladder cancer	0.000219	0.00125	CcSEcCtD
Mifepristone—Malnutrition—Epirubicin—urinary bladder cancer	0.000219	0.00125	CcSEcCtD
Mifepristone—Diarrhoea—Etoposide—urinary bladder cancer	0.000218	0.00124	CcSEcCtD
Mifepristone—Nausea—Fluorouracil—urinary bladder cancer	0.000218	0.00124	CcSEcCtD
Mifepristone—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000217	0.00124	CcSEcCtD
Mifepristone—Back pain—Epirubicin—urinary bladder cancer	0.000212	0.00121	CcSEcCtD
Mifepristone—Angiopathy—Doxorubicin—urinary bladder cancer	0.000211	0.0012	CcSEcCtD
Mifepristone—Malaise—Methotrexate—urinary bladder cancer	0.000211	0.0012	CcSEcCtD
Mifepristone—Dizziness—Etoposide—urinary bladder cancer	0.000211	0.0012	CcSEcCtD
Mifepristone—Muscle spasms—Epirubicin—urinary bladder cancer	0.00021	0.0012	CcSEcCtD
Mifepristone—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.00021	0.00119	CcSEcCtD
Mifepristone—Chills—Doxorubicin—urinary bladder cancer	0.000209	0.00119	CcSEcCtD
Mifepristone—Nausea—Cisplatin—urinary bladder cancer	0.000206	0.00118	CcSEcCtD
Mifepristone—Mental disorder—Doxorubicin—urinary bladder cancer	0.000204	0.00116	CcSEcCtD
Mifepristone—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000203	0.00116	CcSEcCtD
Mifepristone—Vomiting—Etoposide—urinary bladder cancer	0.000202	0.00115	CcSEcCtD
Mifepristone—Malnutrition—Doxorubicin—urinary bladder cancer	0.000202	0.00115	CcSEcCtD
Mifepristone—Rash—Etoposide—urinary bladder cancer	0.000201	0.00114	CcSEcCtD
Mifepristone—Dermatitis—Etoposide—urinary bladder cancer	0.000201	0.00114	CcSEcCtD
Mifepristone—Headache—Etoposide—urinary bladder cancer	0.0002	0.00114	CcSEcCtD
Mifepristone—Arthralgia—Methotrexate—urinary bladder cancer	0.000199	0.00113	CcSEcCtD
Mifepristone—Myalgia—Methotrexate—urinary bladder cancer	0.000199	0.00113	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000198	0.00113	CcSEcCtD
Mifepristone—Malaise—Epirubicin—urinary bladder cancer	0.000197	0.00112	CcSEcCtD
Mifepristone—Discomfort—Methotrexate—urinary bladder cancer	0.000197	0.00112	CcSEcCtD
Mifepristone—Back pain—Doxorubicin—urinary bladder cancer	0.000196	0.00112	CcSEcCtD
Mifepristone—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000195	0.00111	CcSEcCtD
Mifepristone—Infection—Methotrexate—urinary bladder cancer	0.00019	0.00108	CcSEcCtD
Mifepristone—Nausea—Etoposide—urinary bladder cancer	0.000189	0.00108	CcSEcCtD
Mifepristone—Hypertension—Epirubicin—urinary bladder cancer	0.000189	0.00108	CcSEcCtD
Mifepristone—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000188	0.00107	CcSEcCtD
Mifepristone—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000187	0.00107	CcSEcCtD
Mifepristone—Myalgia—Epirubicin—urinary bladder cancer	0.000186	0.00106	CcSEcCtD
Mifepristone—Arthralgia—Epirubicin—urinary bladder cancer	0.000186	0.00106	CcSEcCtD
Mifepristone—Anxiety—Epirubicin—urinary bladder cancer	0.000186	0.00106	CcSEcCtD
Mifepristone—Skin disorder—Methotrexate—urinary bladder cancer	0.000185	0.00106	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000185	0.00105	CcSEcCtD
Mifepristone—Discomfort—Epirubicin—urinary bladder cancer	0.000184	0.00105	CcSEcCtD
Mifepristone—Malaise—Doxorubicin—urinary bladder cancer	0.000183	0.00104	CcSEcCtD
Mifepristone—Dry mouth—Epirubicin—urinary bladder cancer	0.000182	0.00104	CcSEcCtD
Mifepristone—Anorexia—Methotrexate—urinary bladder cancer	0.000182	0.00104	CcSEcCtD
Mifepristone—Oedema—Epirubicin—urinary bladder cancer	0.000179	0.00102	CcSEcCtD
Mifepristone—Hypotension—Methotrexate—urinary bladder cancer	0.000178	0.00102	CcSEcCtD
Mifepristone—Infection—Epirubicin—urinary bladder cancer	0.000177	0.00101	CcSEcCtD
Mifepristone—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000175	0.000998	CcSEcCtD
Mifepristone—Hypertension—Doxorubicin—urinary bladder cancer	0.000175	0.000996	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000174	0.00099	CcSEcCtD
Mifepristone—Skin disorder—Epirubicin—urinary bladder cancer	0.000173	0.000988	CcSEcCtD
Mifepristone—Insomnia—Methotrexate—urinary bladder cancer	0.000173	0.000983	CcSEcCtD
Mifepristone—Myalgia—Doxorubicin—urinary bladder cancer	0.000172	0.000982	CcSEcCtD
Mifepristone—Arthralgia—Doxorubicin—urinary bladder cancer	0.000172	0.000982	CcSEcCtD
Mifepristone—Anxiety—Doxorubicin—urinary bladder cancer	0.000172	0.000979	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000171	0.000975	CcSEcCtD
Mifepristone—Discomfort—Doxorubicin—urinary bladder cancer	0.00017	0.00097	CcSEcCtD
Mifepristone—Anorexia—Epirubicin—urinary bladder cancer	0.00017	0.00097	CcSEcCtD
Mifepristone—Dyspnoea—Methotrexate—urinary bladder cancer	0.00017	0.000969	CcSEcCtD
Mifepristone—Somnolence—Methotrexate—urinary bladder cancer	0.00017	0.000966	CcSEcCtD
Mifepristone—Dry mouth—Doxorubicin—urinary bladder cancer	0.000169	0.00096	CcSEcCtD
Mifepristone—Hypotension—Epirubicin—urinary bladder cancer	0.000167	0.000951	CcSEcCtD
Mifepristone—Decreased appetite—Methotrexate—urinary bladder cancer	0.000166	0.000945	CcSEcCtD
Mifepristone—Oedema—Doxorubicin—urinary bladder cancer	0.000165	0.000941	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000165	0.000939	CcSEcCtD
Mifepristone—Fatigue—Methotrexate—urinary bladder cancer	0.000164	0.000937	CcSEcCtD
Mifepristone—Infection—Doxorubicin—urinary bladder cancer	0.000164	0.000935	CcSEcCtD
Mifepristone—Pain—Methotrexate—urinary bladder cancer	0.000163	0.00093	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000163	0.000927	CcSEcCtD
Mifepristone—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000162	0.000923	CcSEcCtD
Mifepristone—Insomnia—Epirubicin—urinary bladder cancer	0.000161	0.00092	CcSEcCtD
Mifepristone—Skin disorder—Doxorubicin—urinary bladder cancer	0.00016	0.000914	CcSEcCtD
Mifepristone—Dyspnoea—Epirubicin—urinary bladder cancer	0.000159	0.000907	CcSEcCtD
Mifepristone—Somnolence—Epirubicin—urinary bladder cancer	0.000159	0.000904	CcSEcCtD
Mifepristone—Anorexia—Doxorubicin—urinary bladder cancer	0.000157	0.000897	CcSEcCtD
Mifepristone—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000157	0.000896	CcSEcCtD
Mifepristone—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000156	0.000889	CcSEcCtD
Mifepristone—Decreased appetite—Epirubicin—urinary bladder cancer	0.000155	0.000884	CcSEcCtD
Mifepristone—Hypotension—Doxorubicin—urinary bladder cancer	0.000154	0.00088	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000154	0.000878	CcSEcCtD
Mifepristone—Fatigue—Epirubicin—urinary bladder cancer	0.000154	0.000877	CcSEcCtD
Mifepristone—Constipation—Epirubicin—urinary bladder cancer	0.000153	0.00087	CcSEcCtD
Mifepristone—Pain—Epirubicin—urinary bladder cancer	0.000153	0.00087	CcSEcCtD
Mifepristone—Urticaria—Methotrexate—urinary bladder cancer	0.000152	0.000864	CcSEcCtD
Mifepristone—Body temperature increased—Methotrexate—urinary bladder cancer	0.000151	0.000859	CcSEcCtD
Mifepristone—Abdominal pain—Methotrexate—urinary bladder cancer	0.000151	0.000859	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00015	0.000858	CcSEcCtD
Mifepristone—Insomnia—Doxorubicin—urinary bladder cancer	0.000149	0.000851	CcSEcCtD
Mifepristone—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000147	0.000839	CcSEcCtD
Mifepristone—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000147	0.000838	CcSEcCtD
Mifepristone—Somnolence—Doxorubicin—urinary bladder cancer	0.000147	0.000837	CcSEcCtD
Mifepristone—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000146	0.000832	CcSEcCtD
Mifepristone—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000144	0.000818	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000143	0.000813	CcSEcCtD
Mifepristone—Fatigue—Doxorubicin—urinary bladder cancer	0.000142	0.000812	CcSEcCtD
Mifepristone—Urticaria—Epirubicin—urinary bladder cancer	0.000142	0.000808	CcSEcCtD
Mifepristone—Constipation—Doxorubicin—urinary bladder cancer	0.000141	0.000805	CcSEcCtD
Mifepristone—Pain—Doxorubicin—urinary bladder cancer	0.000141	0.000805	CcSEcCtD
Mifepristone—Abdominal pain—Epirubicin—urinary bladder cancer	0.000141	0.000804	CcSEcCtD
Mifepristone—Body temperature increased—Epirubicin—urinary bladder cancer	0.000141	0.000804	CcSEcCtD
Mifepristone—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000141	0.000801	CcSEcCtD
Mifepristone—Asthenia—Methotrexate—urinary bladder cancer	0.000137	0.00078	CcSEcCtD
Mifepristone—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000136	0.000776	CcSEcCtD
Mifepristone—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000135	0.00077	CcSEcCtD
Mifepristone—Pruritus—Methotrexate—urinary bladder cancer	0.000135	0.000769	CcSEcCtD
Mifepristone—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000132	0.00075	CcSEcCtD
Mifepristone—Urticaria—Doxorubicin—urinary bladder cancer	0.000131	0.000748	CcSEcCtD
Mifepristone—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000131	0.000744	CcSEcCtD
Mifepristone—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000131	0.000744	CcSEcCtD
Mifepristone—Diarrhoea—Methotrexate—urinary bladder cancer	0.000131	0.000744	CcSEcCtD
Mifepristone—Asthenia—Epirubicin—urinary bladder cancer	0.000128	0.00073	CcSEcCtD
Mifepristone—Pruritus—Epirubicin—urinary bladder cancer	0.000126	0.00072	CcSEcCtD
Mifepristone—Dizziness—Methotrexate—urinary bladder cancer	0.000126	0.000719	CcSEcCtD
Mifepristone—Diarrhoea—Epirubicin—urinary bladder cancer	0.000122	0.000696	CcSEcCtD
Mifepristone—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000122	0.000694	CcSEcCtD
Mifepristone—Vomiting—Methotrexate—urinary bladder cancer	0.000121	0.000691	CcSEcCtD
Mifepristone—Rash—Methotrexate—urinary bladder cancer	0.00012	0.000685	CcSEcCtD
Mifepristone—Dermatitis—Methotrexate—urinary bladder cancer	0.00012	0.000685	CcSEcCtD
Mifepristone—Headache—Methotrexate—urinary bladder cancer	0.00012	0.000681	CcSEcCtD
Mifepristone—Asthenia—Doxorubicin—urinary bladder cancer	0.000119	0.000675	CcSEcCtD
Mifepristone—Dizziness—Epirubicin—urinary bladder cancer	0.000118	0.000673	CcSEcCtD
Mifepristone—Pruritus—Doxorubicin—urinary bladder cancer	0.000117	0.000666	CcSEcCtD
Mifepristone—Vomiting—Epirubicin—urinary bladder cancer	0.000114	0.000647	CcSEcCtD
Mifepristone—Nausea—Methotrexate—urinary bladder cancer	0.000113	0.000646	CcSEcCtD
Mifepristone—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000113	0.000644	CcSEcCtD
Mifepristone—Rash—Epirubicin—urinary bladder cancer	0.000113	0.000641	CcSEcCtD
Mifepristone—Dermatitis—Epirubicin—urinary bladder cancer	0.000112	0.000641	CcSEcCtD
Mifepristone—Headache—Epirubicin—urinary bladder cancer	0.000112	0.000637	CcSEcCtD
Mifepristone—Dizziness—Doxorubicin—urinary bladder cancer	0.000109	0.000622	CcSEcCtD
Mifepristone—Nausea—Epirubicin—urinary bladder cancer	0.000106	0.000604	CcSEcCtD
Mifepristone—Vomiting—Doxorubicin—urinary bladder cancer	0.000105	0.000599	CcSEcCtD
Mifepristone—Rash—Doxorubicin—urinary bladder cancer	0.000104	0.000594	CcSEcCtD
Mifepristone—Dermatitis—Doxorubicin—urinary bladder cancer	0.000104	0.000593	CcSEcCtD
Mifepristone—Headache—Doxorubicin—urinary bladder cancer	0.000103	0.00059	CcSEcCtD
Mifepristone—Nausea—Doxorubicin—urinary bladder cancer	9.81e-05	0.000559	CcSEcCtD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	6.13e-05	0.000491	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6e-05	0.000481	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—TYMP—urinary bladder cancer	5.99e-05	0.000479	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—PPARG—urinary bladder cancer	5.97e-05	0.000478	CbGpPWpGaD
Mifepristone—AR—Gene Expression—SMC1A—urinary bladder cancer	5.96e-05	0.000477	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	5.91e-05	0.000473	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.75e-05	0.00046	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—CREBBP—urinary bladder cancer	5.74e-05	0.000459	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	5.7e-05	0.000456	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	5.7e-05	0.000456	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	5.63e-05	0.000451	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	5.42e-05	0.000434	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—NAT2—urinary bladder cancer	5.41e-05	0.000433	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	5.39e-05	0.000432	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	5.37e-05	0.00043	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	5.27e-05	0.000422	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—NCOR1—urinary bladder cancer	5.27e-05	0.000422	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—RBX1—urinary bladder cancer	5.25e-05	0.000421	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—TYMP—urinary bladder cancer	5.22e-05	0.000418	CbGpPWpGaD
Mifepristone—AR—Gene Expression—ESR2—urinary bladder cancer	5.2e-05	0.000416	CbGpPWpGaD
Mifepristone—ABCC1—Disease—ENO2—urinary bladder cancer	5.17e-05	0.000414	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	5.13e-05	0.000411	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	4.99e-05	0.000399	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—ESR1—urinary bladder cancer	4.97e-05	0.000398	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	4.96e-05	0.000397	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—ERCC2—urinary bladder cancer	4.95e-05	0.000396	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TSC1—urinary bladder cancer	4.94e-05	0.000396	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	4.92e-05	0.000394	CbGpPWpGaD
Mifepristone—ABCC1—Disease—RBX1—urinary bladder cancer	4.9e-05	0.000392	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	4.84e-05	0.000388	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—NAT2—urinary bladder cancer	4.72e-05	0.000378	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	4.72e-05	0.000378	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	4.71e-05	0.000377	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—JAG1—urinary bladder cancer	4.7e-05	0.000377	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTO2—urinary bladder cancer	4.7e-05	0.000376	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NAT1—urinary bladder cancer	4.7e-05	0.000376	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—RRM2—urinary bladder cancer	4.67e-05	0.000374	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	4.67e-05	0.000374	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	4.65e-05	0.000372	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	4.58e-05	0.000367	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—PPARG—urinary bladder cancer	4.53e-05	0.000363	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—SMC1A—urinary bladder cancer	4.52e-05	0.000362	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	4.52e-05	0.000362	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—MYC—urinary bladder cancer	4.47e-05	0.000358	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NAT1—urinary bladder cancer	4.43e-05	0.000355	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	4.43e-05	0.000355	CbGpPWpGaD
Mifepristone—ABCC1—Disease—JAG1—urinary bladder cancer	4.38e-05	0.000351	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—CREBBP—urinary bladder cancer	4.35e-05	0.000349	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ENO2—urinary bladder cancer	4.33e-05	0.000346	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—HPGDS—urinary bladder cancer	4.33e-05	0.000346	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.3e-05	0.000344	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	4.3e-05	0.000344	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GSTT1—urinary bladder cancer	4.2e-05	0.000336	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—ESR1—urinary bladder cancer	4.14e-05	0.000331	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.13e-05	0.000331	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—RRM2—urinary bladder cancer	4.08e-05	0.000326	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	4.05e-05	0.000324	CbGpPWpGaD
Mifepristone—AR—Gene Expression—NCOR1—urinary bladder cancer	4.01e-05	0.000321	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.99e-05	0.00032	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—ESR2—urinary bladder cancer	3.94e-05	0.000316	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	3.94e-05	0.000316	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.93e-05	0.000315	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	3.87e-05	0.00031	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	3.86e-05	0.000309	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—S100B—urinary bladder cancer	3.81e-05	0.000305	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—PPARG—urinary bladder cancer	3.77e-05	0.000302	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	3.77e-05	0.000302	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ENO2—urinary bladder cancer	3.77e-05	0.000302	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—TYMP—urinary bladder cancer	3.77e-05	0.000302	CbGpPWpGaD
Mifepristone—AR—Gene Expression—ERCC2—urinary bladder cancer	3.77e-05	0.000302	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	3.66e-05	0.000293	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	3.65e-05	0.000293	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	3.65e-05	0.000292	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—CREBBP—urinary bladder cancer	3.63e-05	0.00029	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PRSS3—urinary bladder cancer	3.56e-05	0.000285	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—NQO1—urinary bladder cancer	3.49e-05	0.000279	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.48e-05	0.000279	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	3.44e-05	0.000276	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NCOR1—urinary bladder cancer	3.42e-05	0.000274	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NAT2—urinary bladder cancer	3.41e-05	0.000273	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—MYC—urinary bladder cancer	3.41e-05	0.000273	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.38e-05	0.000271	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.37e-05	0.00027	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.36e-05	0.000269	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	3.36e-05	0.000269	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.21e-05	0.000257	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NCOR1—urinary bladder cancer	3.19e-05	0.000256	CbGpPWpGaD
Mifepristone—AR—Gene Expression—ESR1—urinary bladder cancer	3.15e-05	0.000252	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.12e-05	0.00025	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.05e-05	0.000245	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—NCOR1—urinary bladder cancer	3.04e-05	0.000244	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—NQO1—urinary bladder cancer	3.04e-05	0.000244	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TERT—urinary bladder cancer	3.02e-05	0.000242	CbGpPWpGaD
Mifepristone—ABCC1—Disease—ERCC2—urinary bladder cancer	3e-05	0.00024	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.95e-05	0.000236	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—RRM2—urinary bladder cancer	2.95e-05	0.000236	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GSTP1—urinary bladder cancer	2.91e-05	0.000233	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	2.9e-05	0.000232	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NAT1—urinary bladder cancer	2.9e-05	0.000232	CbGpPWpGaD
Mifepristone—AR—Gene Expression—PPARG—urinary bladder cancer	2.88e-05	0.00023	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—ERCC2—urinary bladder cancer	2.86e-05	0.000229	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—TYMP—urinary bladder cancer	2.85e-05	0.000228	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MTHFR—urinary bladder cancer	2.82e-05	0.000226	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.81e-05	0.000225	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TERT—urinary bladder cancer	2.81e-05	0.000225	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.79e-05	0.000224	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—FGFR3—urinary bladder cancer	2.77e-05	0.000222	CbGpPWpGaD
Mifepristone—AR—Gene Expression—CREBBP—urinary bladder cancer	2.76e-05	0.000221	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.73e-05	0.000219	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	2.73e-05	0.000218	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ENO2—urinary bladder cancer	2.73e-05	0.000218	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—TYMS—urinary bladder cancer	2.7e-05	0.000217	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ESR1—urinary bladder cancer	2.69e-05	0.000215	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—TYMP—urinary bladder cancer	2.68e-05	0.000215	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—NCOR1—urinary bladder cancer	2.67e-05	0.000214	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GSTM1—urinary bladder cancer	2.67e-05	0.000214	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.65e-05	0.000212	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	2.65e-05	0.000212	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.6e-05	0.000208	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—MYC—urinary bladder cancer	2.58e-05	0.000207	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.58e-05	0.000207	CbGpPWpGaD
Mifepristone—ABCC1—Disease—FGFR3—urinary bladder cancer	2.58e-05	0.000207	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.58e-05	0.000206	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GPX1—urinary bladder cancer	2.56e-05	0.000205	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	2.54e-05	0.000203	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ERCC2—urinary bladder cancer	2.51e-05	0.000201	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NAT2—urinary bladder cancer	2.43e-05	0.000194	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—ESR1—urinary bladder cancer	2.39e-05	0.000191	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.38e-05	0.000191	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—MTHFR—urinary bladder cancer	2.36e-05	0.000189	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—TYMS—urinary bladder cancer	2.36e-05	0.000189	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CREBBP—urinary bladder cancer	2.36e-05	0.000189	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	2.33e-05	0.000187	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	2.33e-05	0.000187	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IGF1—urinary bladder cancer	2.33e-05	0.000186	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.29e-05	0.000184	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.25e-05	0.00018	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GPX1—urinary bladder cancer	2.23e-05	0.000179	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—RRM2—urinary bladder cancer	2.22e-05	0.000178	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NQO1—urinary bladder cancer	2.2e-05	0.000176	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CREBBP—urinary bladder cancer	2.2e-05	0.000176	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.19e-05	0.000176	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	2.19e-05	0.000175	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PPARG—urinary bladder cancer	2.18e-05	0.000175	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MYC—urinary bladder cancer	2.15e-05	0.000172	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—RHOA—urinary bladder cancer	2.13e-05	0.000171	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—CREBBP—urinary bladder cancer	2.1e-05	0.000168	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—RRM2—urinary bladder cancer	2.09e-05	0.000168	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	2.06e-05	0.000165	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—HPGDS—urinary bladder cancer	2.06e-05	0.000165	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ENO2—urinary bladder cancer	2.06e-05	0.000165	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTT1—urinary bladder cancer	2e-05	0.00016	CbGpPWpGaD
Mifepristone—ABCC1—Disease—RHOA—urinary bladder cancer	1.99e-05	0.000159	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ERBB2—urinary bladder cancer	1.97e-05	0.000158	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ENO2—urinary bladder cancer	1.94e-05	0.000155	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	1.94e-05	0.000155	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PPARG—urinary bladder cancer	1.92e-05	0.000153	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1.88e-05	0.000151	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CXCL8—urinary bladder cancer	1.87e-05	0.00015	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.87e-05	0.00015	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CREBBP—urinary bladder cancer	1.84e-05	0.000147	CbGpPWpGaD
Mifepristone—ABCC1—Disease—ERBB2—urinary bladder cancer	1.84e-05	0.000147	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	1.83e-05	0.000147	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTGS2—urinary bladder cancer	1.8e-05	0.000144	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL2—urinary bladder cancer	1.79e-05	0.000143	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.75e-05	0.00014	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCND1—urinary bladder cancer	1.74e-05	0.00014	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.71e-05	0.000136	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MMP9—urinary bladder cancer	1.69e-05	0.000136	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN1A—urinary bladder cancer	1.69e-05	0.000135	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	1.69e-05	0.000135	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	1.69e-05	0.000135	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTEN—urinary bladder cancer	1.68e-05	0.000135	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PPARG—urinary bladder cancer	1.67e-05	0.000134	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.66e-05	0.000133	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MYC—urinary bladder cancer	1.64e-05	0.000131	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GPX1—urinary bladder cancer	1.61e-05	0.000129	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EP300—urinary bladder cancer	1.61e-05	0.000129	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	1.61e-05	0.000129	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.59e-05	0.000127	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	1.58e-05	0.000127	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN1A—urinary bladder cancer	1.57e-05	0.000126	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTEN—urinary bladder cancer	1.57e-05	0.000126	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.56e-05	0.000125	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SRC—urinary bladder cancer	1.56e-05	0.000125	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTGS2—urinary bladder cancer	1.51e-05	0.000121	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EP300—urinary bladder cancer	1.5e-05	0.00012	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.49e-05	0.000119	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SRC—urinary bladder cancer	1.46e-05	0.000117	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MYC—urinary bladder cancer	1.4e-05	0.000112	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.38e-05	0.000111	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.37e-05	0.00011	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EGFR—urinary bladder cancer	1.37e-05	0.00011	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	1.31e-05	0.000105	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTEN—urinary bladder cancer	1.31e-05	0.000105	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MYC—urinary bladder cancer	1.3e-05	0.000104	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.3e-05	0.000104	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KRAS—urinary bladder cancer	1.29e-05	0.000104	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.29e-05	0.000103	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EGFR—urinary bladder cancer	1.28e-05	0.000102	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.27e-05	0.000102	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.27e-05	0.000102	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.27e-05	0.000102	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.27e-05	0.000102	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—EP300—urinary bladder cancer	1.25e-05	0.0001	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MYC—urinary bladder cancer	1.24e-05	9.96e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.23e-05	9.85e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.22e-05	9.75e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.21e-05	9.71e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PPARG—urinary bladder cancer	1.21e-05	9.67e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—KRAS—urinary bladder cancer	1.21e-05	9.65e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.2e-05	9.59e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.2e-05	9.59e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.2e-05	9.57e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	1.16e-05	9.29e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TP53—urinary bladder cancer	1.15e-05	9.2e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.15e-05	9.19e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTEN—urinary bladder cancer	1.15e-05	9.18e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.13e-05	9.02e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.12e-05	9e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HRAS—urinary bladder cancer	1.1e-05	8.8e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—EP300—urinary bladder cancer	1.09e-05	8.75e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.06e-05	8.48e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HRAS—urinary bladder cancer	1.02e-05	8.2e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.02e-05	8.18e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	9.5e-06	7.61e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PPARG—urinary bladder cancer	9.11e-06	7.3e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CREBBP—urinary bladder cancer	8.76e-06	7.01e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PPARG—urinary bladder cancer	8.59e-06	6.88e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	8.53e-06	6.83e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTEN—urinary bladder cancer	8.29e-06	6.63e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	8.25e-06	6.61e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TYMS—urinary bladder cancer	7.93e-06	6.35e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—EP300—urinary bladder cancer	7.9e-06	6.33e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	7.84e-06	6.27e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	7.84e-06	6.27e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GPX1—urinary bladder cancer	7.5e-06	6.01e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	7.37e-06	5.9e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTGS2—urinary bladder cancer	7.17e-06	5.74e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	6.92e-06	5.54e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	6.76e-06	5.41e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTEN—urinary bladder cancer	6.25e-06	5.01e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—EP300—urinary bladder cancer	5.96e-06	4.77e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTEN—urinary bladder cancer	5.89e-06	4.72e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—EP300—urinary bladder cancer	5.62e-06	4.5e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PPARG—urinary bladder cancer	5.62e-06	4.5e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	5.39e-06	4.32e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	4.42e-06	3.54e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTEN—urinary bladder cancer	3.85e-06	3.08e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.67e-06	2.94e-05	CbGpPWpGaD
